KT Corp/ US48268K1016 /
2024-03-28 9:10:00 PM | Chg. -0.14 | Volume | Bid1:00:00 AM | Ask1:00:00 AM | High | Low |
---|---|---|---|---|---|---|
14.02USD | -0.99% | 927,806 Turnover: 8.16 mill. |
13.80Bid Size: 4,000 | 14.48Ask Size: 100 | 14.13 | 13.97 |
GlobeNewswire
03-21
Global Uranium Mining Output Expected To Rise 11.7% in 2024 Due To Kazakh and Canadian Growth
GlobeNewswire
03-20
Skyharbour’s Partner Company North Shore Uranium Completes Maiden Drill Program and Identifies Eleva...
GlobeNewswire
03-18
Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Eva...
GlobeNewswire
03-11
Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particl...
GlobeNewswire
03-08
Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immun...
GlobeNewswire
02-29
CARBIOS and Landbell Group join forces to increase circularity of PET waste at first biorecycling pl...
GlobeNewswire
02-22
Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Bus...
GlobeNewswire
02-21
Demand Booming as Global Uranium Mining Market Expected To Reach $11.3 Billion By 2030
GlobeNewswire
02-14
Centerra Gold Announces 2023 Year-End Mineral Reserves and Resources and Provides Exploration Update
GlobeNewswire
02-14
Norsk Hydro: Changing the aluminium game - Strengthening position in challenging markets
GlobeNewswire
02-12
Perspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conferen...
GlobeNewswire
02-08
ArcelorMittal S.A.: ArcelorMittal reports fourth quarter and full year 2023 results
GlobeNewswire
02-02
Brookfield Renewable Reports Record Results and Announces 5% Distribution Increase
GlobeNewswire
02-01
Perspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platform